Q3 2018 EPS Estimates for Invacare Co. (IVC) Cut by Analyst
Invacare Co. (NYSE:IVC) – Equities research analysts at KeyCorp dropped their Q3 2018 EPS estimates for shares of Invacare in a note issued to investors on Wednesday, August 15th. KeyCorp analyst M. Mishan now forecasts that the health services provider will post earnings of ($0.30) per share for the quarter, down from their previous estimate of ($0.17). KeyCorp currently has a “Overweight” rating and a $23.00 target price on the stock. KeyCorp also issued estimates for Invacare’s Q4 2018 earnings at ($0.23) EPS, FY2018 earnings at ($1.28) EPS and FY2019 earnings at ($0.50) EPS.
Invacare (NYSE:IVC) last posted its earnings results on Tuesday, August 7th. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.30) by ($0.11). The company had revenue of $246.15 million for the quarter, compared to the consensus estimate of $247.90 million. Invacare had a negative net margin of 6.80% and a negative return on equity of 12.52%.
IVC opened at $15.80 on Monday. The company has a current ratio of 2.10, a quick ratio of 1.41 and a debt-to-equity ratio of 0.64. The stock has a market cap of $555.38 million, a price-to-earnings ratio of -8.19 and a beta of 2.38. Invacare has a 52-week low of $13.13 and a 52-week high of $20.00.
In other news, SVP Dean J. Childers sold 7,000 shares of the company’s stock in a transaction dated Friday, June 29th. The shares were sold at an average price of $18.71, for a total transaction of $130,970.00. Following the completion of the sale, the senior vice president now owns 34,631 shares of the company’s stock, valued at approximately $647,946.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director C Martin Harris sold 2,582 shares of the company’s stock in a transaction dated Wednesday, May 23rd. The shares were sold at an average price of $16.38, for a total transaction of $42,293.16. The disclosure for this sale can be found here. Insiders have sold a total of 33,582 shares of company stock valued at $643,663 in the last ninety days. Insiders own 2.10% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. increased its position in shares of Invacare by 7.7% during the 2nd quarter. BlackRock Inc. now owns 4,966,290 shares of the health services provider’s stock valued at $92,374,000 after purchasing an additional 356,975 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Invacare by 3.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,770,365 shares of the health services provider’s stock worth $48,204,000 after acquiring an additional 88,888 shares in the last quarter. Royce & Associates LP increased its holdings in Invacare by 2.4% in the 2nd quarter. Royce & Associates LP now owns 1,589,533 shares of the health services provider’s stock worth $29,565,000 after acquiring an additional 37,100 shares in the last quarter. Millennium Management LLC increased its holdings in Invacare by 318.5% in the 1st quarter. Millennium Management LLC now owns 1,455,746 shares of the health services provider’s stock worth $25,330,000 after acquiring an additional 1,107,858 shares in the last quarter. Finally, Elk Creek Partners LLC increased its holdings in Invacare by 53.0% in the 1st quarter. Elk Creek Partners LLC now owns 1,388,380 shares of the health services provider’s stock worth $24,158,000 after acquiring an additional 480,755 shares in the last quarter.
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific.
Read More: How to Invest in Growth Stocks
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.